Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information


EU orphan designation number: EU/3/13/1223   
Active ingredient: Inecalcitol
Indication: Treatment of chronic lymphocytic leukaemia / small lymphocytic lymphoma
Sponsor: Hybrigenics SA
3-5 impasse Reille, 75014 Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/01/2014 Orphan designation EMA/OD/109/13 (2014)293 of 16/01/2014